Arthroscopic elbow debridement effectively treated posttraumatic, degenerative OA
Click Here to Manage Email Alerts
CHICAGO — According to presented results, arthroscopic debridement is an equally effective surgical treatment for both degenerative osteoarthritis and posttraumatic arthritis of the elbow with positive midterm outcomes.
“[Degenerative and posttraumatic arthritis] have distinctive characteristics that distinguish one from the other, including the age or sex in which they commonly present and location within the elbow,” Dennis Debernardis, DO, said in his presentation at the American Academy of Orthopaedic Surgeons Annual Meeting.
Debernardis and colleagues retrospectively analyzed data on 36 patients who underwent arthroscopic debridement of the elbow for primary degenerative osteoarthritis (DOA) and 44 patients who underwent the procedure for posttraumatic arthritis (PTA). The researchers compared outcomes, including survivorship, range of motion (ROM), reoperation, additional nonsurgical intervention, complications, pain and satisfaction, between the cohorts. Mean follow-up was 7.9 years in the DOA cohort and was 8.6 years in the PTA cohort.
Overall, both cohorts demonstrated similar improvements in VAS pain scores and ROM.
At final follow-up, the DOA cohort had a reoperation rate of 5.6% and the PTA cohort had a reoperation rate of 11.4%; however, Debernardis and colleagues determined this difference was not statistically significant. Additionally, researchers found no statistical differences in survivorship or any patient-reported outcomes between cohorts.
“Interestingly, this survivorship compared favorably to that of alternatively available surgical treatment options for these same pathologies,” Debernardis said. “That’s important because the goal of this surgery is to improve patient pain and function and prevent the need for that next surgery that may be slightly more morbid with results that may not last quite as long,” he added.